In April 2025, according to an article published by the Heart Rhythm Society, a recent clinical study, TRANSFORM-AF, found that GLP-1 receptor agonists (GLP-1 RAs), typically used for diabetes, may reduce atrial fibrillation (AF)-related events in patients with both obesity and AF
So when a treatment plan helps lower systolic blood pressure, it may support better cardiometabolic health
Stick with BAC water unless you have a very specific, data-driven reason not to
GLP-1 Medications for Weight Management Wegovy has reshaped obesity treatment by addressing the biological drivers of weight gain , not just calories
Place your semaglutide inside immediately upon arrival
This injectable pen is designed to improve blood sugar control in conjunction with diet and exercise